We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




MRSA AI Diagnostics Software Helps Enhance Microbiology Lab Efficiency and Workflow

By LabMedica International staff writers
Posted on 29 May 2023

Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant risk in hospital environments, leading to serious complications like bloodstream or surgical-site infections, sepsis, and even death. More...

Lab tests are necessary to confirm whether an infection is due to MRSA, and the capacity to conduct these tests efficiently and effectively could profoundly influence patient care. However, labs often face hurdles such as fluctuating sample volumes, staff shortages, financial constraints from budget cuts, and shifting diagnostic methods. To address these challenges and facilitate efficient, timely, and cost-effective clinical bacteriological testing, a new solution now offers comprehensive lab automation for clinical microbiology laboratories.

Becton, Dickinson and Company’s (BD, Franklin Lakes, NJ, USA) new BD Kiestra MRSA imaging application employs artificial intelligence (AI) to analyze bacterial growth and release negative samples with minimal human intervention. The BD Kiestra MRSA application employs AI to automate the traditionally laborious and time-consuming task of inspecting Petri dishes to ascertain bacterial growth, allowing medical lab scientists and technicians to devote more time to high-priority analyses.

The application can evaluate individual samples or group together numerous plates showing non-significant growth for batch review and release of negative results, potentially easing the administrative load on technicians. The MRSA imaging application utilizes AI algorithms to identify specific culture characteristics on the BBL CHROMagar MRSA II plate. Based on this information and analysis by BD Synapsys informatics, plate images are automatically arranged and sorted into meaningful worklists for lab scientists and technicians. This AI-driven imaging application, backed by the BD BBL CHROMagar MRSA II screening plates and powered by BD Synapsys Informatics Solution, is compatible with both standalone BD Kiestra ReadA systems and track-based BD Kiestra lab automation solutions.

"The pandemic created significant and ongoing labor challenges in laboratories, and reading plates is a labor-intense, potentially error-prone process in microbiology," said Nikos Pavlidis, vice president and general manager for Diagnostics at BD. "The use of this imaging application to automatically organize specimens in meaningful worklists helps use limited laboratory staff more efficiently and allows lab personnel to bring their expertise to bear on more critical and complex specimens."

Related Links:
BD 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.